Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 7/20 | 0.52 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.43 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.43 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6513309 | 0.92 | TYMP (0.58) | TYMPADORA1P2RY12ADORA2AADORA2B | |
| SCHEMBL7708120 | 0.92 | TYMP (0.58) | TYMPADORA1P2RY12ADORA2AADORA2B | |
| SCHEMBL30396368 | 0.92 | TYMP (0.58) | TYMPADORA1P2RY12ADORA2AADORA2B | |
| SCHEMBL23650062 | 0.92 | TYMP (0.58) | TYMPADORA1P2RY12ADORA2AADORA2B | |
| SCHEMBL30091055 | 0.92 | TYMP (0.58) | TYMPADORA1P2RY12ADORA2AADORA2B | |
| SCHEMBL30689461 | 0.91 | TYMP (0.58) | TYMPADORA1P2RY12ADORA2AADORA2B | |
| SCHEMBL29792804 | 0.89 | TYMP (0.50) | TYMPPRMT6ADORA1P2RY12ADORA2A | |
| SCHEMBL30679323 | 0.88 | TYMP (0.49) | TYMPPRMT6ADORA1P2RY12ADORA2A | |
| SCHEMBL917678 | 0.88 | TYMP (0.67) | TYMPADORA1P2RY12 | |
| SCHEMBL17304362 | 0.88 | TYMP (0.67) | TYMPADORA1P2RY12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6359124-B1 | NUCLEOTIDE SEQUENCES FOR USE IN THE DIAGNOSIS, DETECTION AND TREATMENT OF ARRHYTHMIA, LONG Q-T SYNDROME AND CANCERS | ISIS PHARMACEUTICALS, INC. | 2002-03-19 | — | — | US | disclosed |